team, led by researchers from Northwestern University, has made an incredible finding while studying patient reports from ten different countries. The countries they considered for the research as data sources are China, France, Germany, Italy, Iran, South Korea, Spain, Switzerland, the United Kingdom, and the United States. The findings discovered that the patients who died after being infected by the virus had a deficiency of vitamin D. The patients from countries with a more significant number of cases like the U.K., Spain, and Italy had a lower level of vitamin D than those from lesser impacted countries. However, Vadim Backman, the head of the research group, says that this would not mean that they needed to administer vitamin D in all patients, although more research was required in this area, and this could eventually lead to easily identifiable and achievable therapeutic targets.
Backman and his team were motivated to conduct this research as they noticed that there was a discontinuity in the number of cases across the world. However, at first, speculations pertaining to the hypothesis were prompted. Like the difference in population density, age difference in the population, level, and quality of healthcare and facilitation, etc. This did not convince Backman, and he continued to venture further into the study with his team. Now, Danesh Khan, who is an associate of Backman, states that it is the overactive immune system of the body that results in the hyper-inflammation of the lungs, causing a respiratory syndrome.
Once the lungs get affected, they become prone to other conditions like cytokine storms. He says that these conditions are what causes deaths and not the virus itself. Professor Backman feels that the reason for this is the deficiency of vitamin D. The formula and dosage that can be standardized for universal use remain to be formulated.